Abstract
The annual incidence of myasthenia gravis (MG) ranges from 3 to 30 per 1,000,000 people. Since the mid-1980s, an increasing incidence has been reported, mainly due to late-onset MG. Whether the increase was due to population aging, improved diagnosis and case collection, or a true excess of incidence cases is still under debate. We used a complete enumeration approach by reviewing all possible sources of case collection in the province of Ferrara, Italy, to estimate the MG incidence and its temporal trend over the study period (1985–2007). The mean annual age-adjusted incidence of MG was 18 per 1,000,000, without any significant temporal trend. The incidence rates in the period 1985–1990 were 14 both for early and late-onset MG. Thereafter, a significant increase in incidence of late-onset MG (p < 0.05), and a decrease in early onset MG were detected (p < 0.01). These findings were related to nonthymoma MG. The median age at onset of the disease steadily increased over time. A changing pattern of MG incidence with an increase in frequency of late-onset and a decrease of early onset MG was found in the last years, giving a significant shift to older age at onset of the disease. Unknown environmental factors may have driven this change in MG epidemiology.
Similar content being viewed by others
References
McGrogan A, Sneddon S, de Vries CS (2010) The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 34:171–183
Phillips LH 2nd, Tomer JC, Anderson MS, Cox GM (1992) The epidemiology of myasthenia gravis in central and western Virginia. Neurology 42:1888–1893
Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I (2003) Myasthenia gravis. A higher-than-expected incidence in the elderly. Neurology 60:1024–1026
Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 65:928–930
Matsui N, Nakane S, Nakagawa Y, Kondo K, Mitsui T, Matsumoto T, Arisaswa K, Kaji R (2009) Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry 80:1168–1171
Aarli JA (2008) Myasthenia gravis in the elderly. Is it different? Ann N Y Acad Sci 1132:238–243
Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM, the UK myasthenia gravis survey (2003) Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 74:1105–1108
Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia Gravis (2000) Recommendation for clinical research standards. Neurology 55:16–23
Somnier FE, Keiding N, Paulson OB (1991) Epidemiology of Myasthenia Gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol 48:733–739
Aarli JA (1999) Late-onset myasthenia gravis: a changing scene. Arch Neurol 56:25–27
Robertson NP, Deans J, Compston DAS (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire England. J Neurol Neurosurg Psychiatry 65:492–496
Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M, Tsantili P, Papapetropoulos T, Tzartos SJ (2001) Epidemiology of myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 71:352–356
Heldal AT, Owe JF, Gilhus NE, Romi F (2009) Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology 73:150–151
Emilia-Romagna Study Group on Clinical, Epidemiological Problems in Neurology (1998) Incidence of myasthenia gravis in the Emilia-Romagna region: a prospective multicenter study. Neurology 51:255–258
Casetta I, Fallica E, Govoni V, Azzini C, Tola M, Granieri E (2004) Incidence of myasthenia gravis in the province of Ferrara. A community-based study. Neuroepidemiology 23:281–284
Compston DA, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579–601
Acknowledgments
This work was supported by grants from the Italian Ministry of University and from Fondazione Cassa di Risparmio di Ferrara.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Casetta, I., Groppo, E., De Gennaro, R. et al. Myasthenia gravis: a changing pattern of incidence. J Neurol 257, 2015–2019 (2010). https://doi.org/10.1007/s00415-010-5651-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-010-5651-z